Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches for precision immunotherapy in oncology and autoimmune diseases, will present updated clinical and ...

Researchers at the Francis Crick Institute have shown that water influx is necessary for immune cells called T cells to activate and divide in response to a threat. T cells defend against ...

The therapy, a fully human monoclonal antibody, targets a newly identified immune checkpoint protein that could enhance ...

The therapy, a fully human monoclonal antibody, targets a newly identified immune checkpoint protein that could enhance ...

INAB READ THE FULL INAB RESEARCH REPORT Following the announcement of its new γδ T cell engager platform INB-600, IN8bio, Inc ...

Ten years of substantial work by Université de Montréal immunologist Nathalie Labrecque's team at the Montreal Clinical ...

Autoimmunity is a process by which the immune system reacts against the body's own tissues. Chronic and/or excessive autoimmune responses can result in autoimmune diseases. Once seen as a passive ...

Our blood consists of many cell types that develop through different stages from a precursor type -- the blood stem cell. An international research team has now investigated the developmental pathways ...

Our blood consists of many cell types that develop through different stages from a precursor type—the blood stem cell. An ...

The AACR poster presentation will provide an update on the data in AML patients most recently presented at the American Society of Hematology (ASH) Annual Meeting 2024 showing that ICT01 administered ...

Results from Phase 2a Trial demonstrate a good safety and tolerability profile of VXM01 and Avelumab Combination Therapy in ...